The purpose of this prospective clinical data collection is to compare the outcomes of two different tibial bearings: the Maxim Pop Top Tibia and Maxim Modular Tibia...
Date First Received: December 17, 2007
Last Updated: March 18, 2009
Verified by: Biomet, Inc., March 2009
Clinical Trial Phase: N/A | Start Date: May 2004
Overall Status: Terminated
Estimated Enrollment: 31
Brief Summary
Official Title: “A Randomized Data Collection of the Maxim® Knee System With Removable Molded Polyethylene Tibia and the Regular Maxim® Knee System”
Condition Keyword(s):
The purpose of this prospective clinical data collection is to compare the outcomes of two different tibial bearings: the Maxim Pop Top Tibia and Maxim Modular Tibia.
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment
Study Primary Completion Date: November 2007
Detailed Clinical Trial Description
The purpose of this prospective clinical data collection is to document and compare the performance and clinical outcomes between the Maxim Knee System with Removable Molded Poly Tibia and the Maxim Knee System with Modular Tibial Bearing as two treatment groups.
FDA has cleared these devices via Premarket Notification 510(k)'s K991753, K984623, K993159, K010027. The data gathered will be collated and used to provide feedback to designing engineers, support marketing efforts and answer potential questions from reimbursement agencies.
Intervention(s) in this Clinical Trial
- Device: Maxim® Knee System with Removable Molded Polyethylene Tibia
- Used for total knee replacements
- Device: Regular Maxim® Knee System
- Used for total knee replacements
Arms, Groups and Cohorts in this Clinical Trial
- Other: 1
- Maxim Pop Top Tibia
- Other: 2
- Maxim Regular Tibia
Outcome Measures for this Clinical Trial
Primary Measures
- Knee Society Score, Radiographic information
- Time Frame: 10 years
Safety Issue?: No
- Time Frame: 10 years
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients with painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
- Patients requiring correction of varus, valgus, or posttraumatic deformity.
- Patients requiring correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure.
Exclusion Criteria:
- Patients with infection, sepsis, or osteomyelitis.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Biomet Orthopedics, LLC
Overall Clinical Trial Officials and Contacts
Russell Wagner, MD Principal Investigator Harris Methodist Hospital
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00579059
Study ID Number: 62-U-007
ClinicalTrials.gov Identifier: NCT00579059
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.